Parents Skeptical of New Home Flu Vaccine Approval
Submitted by MAGA
Posted 3 hours ago
**Controversial Flu Vaccine Approved for Home Use: Parents Remain Skeptical**
In a bold move that has raised eyebrows across the nation, the FDA has granted approval for AstraZeneca’s FluMist, a nasal flu vaccine, to be administered at home by parents instead of healthcare professionals.
This decision comes despite the vaccine's troubled history, including its initial withdrawal from the market in 2016 due to ineffectiveness and reports linking it to serious adverse reactions in children.
Previously, FluMist was only available in medical settings, and the decision to allow self-administration raises substantial concerns among parents and healthcare experts alike.
Critics are questioning the safety and efficacy of this vaccine, which has been associated with serious side effects like Guillain-Barré syndrome and even death.
Reports indicate a staggering total of over 11,000 adverse events linked to FluMist, including 943 classified as serious— and these numbers might only scratch the surface, as less than 1% of all adverse events are reported to the Vaccine Adverse Event Reporting System (VAERS).
Dr. Peter McCullough, a prominent cardiologist, voiced strong concerns over the authorization of FluMist for at-home use, indicating the increased hospitalization risks for children under two and warning that the vaccine's live virus could potentially become a health crisis for those who are immunocompromised.
With current data showing a minimal chance of children contracting the flu, many health experts are advocating for alternative health measures, including natural immunity boosters, instead of relying on FluMist or similar vaccinations.
The FDA claims this newest version of FluMist offers greater convenience for families, yet some parents worry that ease of access could lead to misuse or insufficient knowledge about its potential dangers.
Notably, AstraZeneca has faced scrutiny over its safety track record with its COVID-19 vaccine, which was pulled from the market after serious adverse events were reported post-vaccination.
As debates surrounding vaccine safety intensify, the FDA's approval has only added fuel to the fire, sparking a national conversation about parental rights, health choices, and the responsibilities that come with vaccination.
In a corner where many worry about medical overreach, this latest move by regulators seems to clash with traditional values of informed decision-making and health autonomy that resonate strongly with conservative families across the country.
With calls for greater transparency and safety in vaccination policies, parents are left grappling with this new reality, questioning whether they have all the necessary information to safeguard their children's health effectively.
Sources:
childrenshealthdefense.org
hollywoodreporter.com
ca.news.yahoo.com
In a bold move that has raised eyebrows across the nation, the FDA has granted approval for AstraZeneca’s FluMist, a nasal flu vaccine, to be administered at home by parents instead of healthcare professionals.
This decision comes despite the vaccine's troubled history, including its initial withdrawal from the market in 2016 due to ineffectiveness and reports linking it to serious adverse reactions in children.
Previously, FluMist was only available in medical settings, and the decision to allow self-administration raises substantial concerns among parents and healthcare experts alike.
Critics are questioning the safety and efficacy of this vaccine, which has been associated with serious side effects like Guillain-Barré syndrome and even death.
Reports indicate a staggering total of over 11,000 adverse events linked to FluMist, including 943 classified as serious— and these numbers might only scratch the surface, as less than 1% of all adverse events are reported to the Vaccine Adverse Event Reporting System (VAERS).
Dr. Peter McCullough, a prominent cardiologist, voiced strong concerns over the authorization of FluMist for at-home use, indicating the increased hospitalization risks for children under two and warning that the vaccine's live virus could potentially become a health crisis for those who are immunocompromised.
With current data showing a minimal chance of children contracting the flu, many health experts are advocating for alternative health measures, including natural immunity boosters, instead of relying on FluMist or similar vaccinations.
The FDA claims this newest version of FluMist offers greater convenience for families, yet some parents worry that ease of access could lead to misuse or insufficient knowledge about its potential dangers.
Notably, AstraZeneca has faced scrutiny over its safety track record with its COVID-19 vaccine, which was pulled from the market after serious adverse events were reported post-vaccination.
As debates surrounding vaccine safety intensify, the FDA's approval has only added fuel to the fire, sparking a national conversation about parental rights, health choices, and the responsibilities that come with vaccination.
In a corner where many worry about medical overreach, this latest move by regulators seems to clash with traditional values of informed decision-making and health autonomy that resonate strongly with conservative families across the country.
With calls for greater transparency and safety in vaccination policies, parents are left grappling with this new reality, questioning whether they have all the necessary information to safeguard their children's health effectively.
Sources:
childrenshealthdefense.org
hollywoodreporter.com
ca.news.yahoo.com
Latest News